CAR123 T cell treatment of relapsed/refractory hematologic malignancies.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-503165-30-00

Acronym

UHKT-CAR123-01

Enrollment

Registered

2024-09-05

Start date

2024-10-23

Completion date

Unknown

Last updated

2024-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukemia., Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndrome, Relapsed/refractory CD123+ hematological malignancies: Acute Myeloid Leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Countries

Czechia

Outcome results